Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Nucleic Acids Res
1997 May 15;2510:1903-12. doi: 10.1093/nar/25.10.1903.
Show Gene links
Show Anatomy links
Binding of type II nuclear receptors and estrogen receptor to full and half-site estrogen response elements in vitro.
Klinge CM
,
Bodenner DL
,
Desai D
,
Niles RM
,
Traish AM
.
Abstract
The mechanism by which retinoids, thyroid hormone (T3) and estrogens modulate the growth of breast cancer cells is unclear. Since nuclear type II nuclear receptors, including retinoic acid receptor (RAR), retinoid X receptor (RXR) and thyroid hormone receptor (TR), bind direct repeats (DR) of the estrogen response elements (ERE) half-site (5'-AGGTCA-3'), we examined the ability of estrogen receptor (ER) versus type II nuclear receptors, i.e. RARalpha, beta and gamma, RXRbeta, TRalpha and TRbeta, to bind various EREs in vitro . ER bound a consensus ERE, containing a perfectly palindromic 17 bp inverted repeat (IR), as a homodimer. In contrast, ER did not bind to a single ERE half-site. Likewise, ER did not bind two tandem (38 bp apart) half-sites, but low ER binding was detected to three tandem copies of the same half-site. RARalpha,beta or gamma bound both ERE and half-site constructs as a homodimer. RXRbeta did not bind full or half-site EREs, nor did RXRbeta enhance RARalpha binding to a full ERE. However, RARalpha and RXRbeta bound a half-site ERE cooperatively forming a dimeric complex. The RARalpha-RXRbeta heterodimer bound the Xenopus vitellogenin B1 estrogen responsive unit, with two non-consensus EREs, with higher affinity than one or two copies of the full or half-site ERE. Both TRalpha and TRbeta bound the full and the half-site ERE as monomers and homodimers and cooperatively as heterodimers with RXRbeta. We suggest that the cellular concentrations of nuclear receptors and their ligands, and the nature of the ERE or half-site sequence and those of its flanking sequences determine the occupation of EREs in estrogen-regulated genes in vivo .
Abbondanza,
Characterization and epitope mapping of a new panel of monoclonal antibodies to estradiol receptor.
1993, Pubmed
Abbondanza,
Characterization and epitope mapping of a new panel of monoclonal antibodies to estradiol receptor.
1993,
Pubmed
Anolik,
Stability of the ligand-estrogen receptor interaction depends on estrogen response element flanking sequences and cellular factors.
1997,
Pubmed
Anolik,
Differential impact of flanking sequences on estradiol- vs 4-hydroxytamoxifen-liganded estrogen receptor binding to estrogen responsive element DNA.
1994,
Pubmed
Anolik,
Cooperative binding of estrogen receptor to DNA depends on spacing of binding sites, flanking sequence, and ligand.
1995,
Pubmed
Aumais,
Function of directly repeated half-sites as response elements for steroid hormone receptors.
1996,
Pubmed
Berry,
Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence.
1989,
Pubmed
Claret,
A shift in the ligand responsiveness of thyroid hormone receptor alpha induced by heterodimerization with retinoid X receptor alpha.
1996,
Pubmed
Dawson,
Correlation of retinoid binding affinity to retinoic acid receptor alpha with retinoid inhibition of growth of estrogen receptor-positive MCF-7 mammary carcinoma cells.
1995,
Pubmed
Demirpence,
Antiestrogenic effects of all-trans-retinoic acid and 1,25-dihydroxyvitamin D3 in breast cancer cells occur at the estrogen response element level but through different molecular mechanisms.
1994,
Pubmed
Driscoll,
Footprint analysis of estrogen receptor binding to adjacent estrogen response elements.
1996,
Pubmed
Forman,
Half-site spacing and orientation determines whether thyroid hormone and retinoic acid receptors and related factors bind to DNA response elements as monomers, homodimers, or heterodimers.
1992,
Pubmed
Giguère,
Retinoic acid receptors and cellular retinoid binding proteins: complex interplay in retinoid signaling.
1994,
Pubmed
Glass,
The thyroid hormone receptor binds with opposite transcriptional effects to a common sequence motif in thyroid hormone and estrogen response elements.
1988,
Pubmed
Glass,
Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers.
1994,
Pubmed
Hoopes,
Kinetic analysis of yeast TFIID-TATA box complex formation suggests a multi-step pathway.
1992,
Pubmed
Horwitz,
Nuclear receptor coactivators and corepressors.
1997,
Pubmed
Joyeux,
In vitro and in vivo interactions between nuclear receptors at estrogen response elements.
1997,
Pubmed
Kato,
Widely spaced, directly repeated PuGGTCA elements act as promiscuous enhancers for different classes of nuclear receptors.
1995,
Pubmed
Klein-Hitpass,
An estrogen-responsive element derived from the 5' flanking region of the Xenopus vitellogenin A2 gene functions in transfected human cells.
1986,
Pubmed
,
Xenbase
Klein-Hitpass,
Synergism of closely adjacent estrogen-responsive elements increases their regulatory potential.
1988,
Pubmed
,
Xenbase
Kliewer,
Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling.
1992,
Pubmed
Klinge,
Cooperative estrogen receptor interaction with consensus or variant estrogen responsive elements in vitro.
1992,
Pubmed
Klinge,
Antiestrogen-liganded estrogen receptor interaction with estrogen responsive element DNA in vitro.
1992,
Pubmed
Klinge,
Site-directed estrogen receptor antibodies stabilize 4-hydroxytamoxifen ligand, but not estradiol, and indicate ligand-specific differences in the recognition of estrogen response element DNA in vitro.
1997,
Pubmed
Klinge,
Dissociation of 4-hydroxytamoxifen, but not estradiol or tamoxifen aziridine, from the estrogen receptor as the receptor binds estrogen response element DNA.
1996,
Pubmed
Kraus,
Identification of multiple, widely spaced estrogen-responsive regions in the rat progesterone receptor gene.
1995,
Pubmed
Lehmann,
Identification of retinoids with nuclear receptor subtype-selective activities.
1991,
Pubmed
Leid,
Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently.
1992,
Pubmed
Linney,
Retinoic acid receptors: transcription factors modulating gene regulation, development, and differentiation.
1992,
Pubmed
Love-Schimenti,
Antiestrogen potentiation of antiproliferative effects of vitamin D3 analogues in breast cancer cells.
1996,
Pubmed
Ludwig,
A microtiter well assay for quantitative measurement of estrogen receptor binding to estrogen-responsive elements.
1991,
Pubmed
Mangelsdorf,
The nuclear receptor superfamily: the second decade.
1996,
Pubmed
Mangelsdorf,
The RXR heterodimers and orphan receptors.
1996,
Pubmed
Marks,
H-2RIIBP expressed from a baculovirus vector binds to multiple hormone response elements.
1992,
Pubmed
Martinez,
The estrogen-responsive element as an inducible enhancer: DNA sequence requirements and conversion to a glucocorticoid-responsive element.
1988,
Pubmed
,
Xenbase
Martinez,
Cooperative binding of estrogen receptor to imperfect estrogen-responsive DNA elements correlates with their synergistic hormone-dependent enhancer activity.
1990,
Pubmed
,
Xenbase
Moon,
Chemoprevention of mammary cancer by retinoids.
1990,
Pubmed
Nagpal,
RARs and RXRs: evidence for two autonomous transactivation functions (AF-1 and AF-2) and heterodimerization in vivo.
1993,
Pubmed
Nunez,
Retinoid X receptor beta and peroxisome proliferator-activated receptor activate an estrogen response element.
1995,
Pubmed
Näär,
The orientation and spacing of core DNA-binding motifs dictate selective transcriptional responses to three nuclear receptors.
1991,
Pubmed
Pavlik,
Hydroxylapatite "batch" assay for estrogen receptors: increased sensitivity over present receptor assays.
1976,
Pubmed
Peale,
Properties of a high-affinity DNA binding site for estrogen receptor.
1988,
Pubmed
,
Xenbase
Perlmann,
Determinants for selective RAR and TR recognition of direct repeat HREs.
1993,
Pubmed
Qiu,
Chicken ovalbumin upstream promoter-transcription factors and their regulation.
1996,
Pubmed
Quick,
Characterization of human retinoic acid receptor alpha 1 expressed in recombinant baculovirus-infected Sf9 insect cells.
1994,
Pubmed
Reginato,
DNA-independent and DNA-dependent mechanisms regulate the differential heterodimerization of the isoforms of the thyroid hormone receptor with retinoid X receptor.
1996,
Pubmed
Rhodes,
Helical periodicity of DNA determined by enzyme digestion.
1980,
Pubmed
Richard,
The human oxytocin gene promoter is regulated by estrogens.
1990,
Pubmed
Roman,
Expression and regulation of retinoic acid receptors in human breast cancer cells.
1992,
Pubmed
Segars,
Inhibition of estrogen-responsive gene activation by the retinoid X receptor beta: evidence for multiple inhibitory pathways.
1993,
Pubmed
Seiler-Tuyns,
Identification of estrogen-responsive DNA sequences by transient expression experiments in a human breast cancer cell line.
1987,
Pubmed
,
Xenbase
Sharif,
v-erbA oncogene function in neoplasia correlates with its ability to repress retinoic acid receptor action.
1991,
Pubmed
Shulemovich,
DNA bending by thyroid hormone receptor: influence of half-site spacing and RXR.
1995,
Pubmed
Sucov,
Characterization of an autoregulated response element in the mouse retinoic acid receptor type beta gene.
1990,
Pubmed
Suva,
Characterization of retinoic acid- and cell-dependent sequences which regulate zif268 gene expression in osteoblastic cells.
1995,
Pubmed
Thompson,
A nuclear protein is required for thyroid hormone receptor binding to an inhibitory half-site in the epidermal growth factor receptor promoter.
1992,
Pubmed
Tini,
Heterodimeric interaction of the retinoic acid and thyroid hormone receptors in transcriptional regulation on the gamma F-crystallin everted retinoic acid response element.
1995,
Pubmed
Traish,
Monoclonal and polyclonal antibodies to human progesterone receptor peptide-(533-547) recognize a specific site in unactivated (8S) and activated (4S) progesterone receptor and distinguish between intact and proteolyzed receptors.
1990,
Pubmed
Tzeng,
Phosphorylation of purified estradiol-liganded estrogen receptor by casein kinase II increases estrogen response element binding but does not alter ligand stability.
1996,
Pubmed
Walker,
Sequence homologies in the region preceding the transcription initiation site of the liver estrogen-responsive vitellogenin and apo-VLDLII genes.
1985,
Pubmed
,
Xenbase
Weisz,
Identification of an estrogen response element upstream of the human c-fos gene that binds the estrogen receptor and the AP-1 transcription factor.
1990,
Pubmed
Williams,
Differential capacity of wild type promoter elements for binding and trans-activation by retinoic acid and thyroid hormone receptors.
1992,
Pubmed
Zechel,
Dimerization interfaces formed between the DNA binding domains determine the cooperative binding of RXR/RAR and RXR/TR heterodimers to DR5 and DR4 elements.
1994,
Pubmed
Zhang,
Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors.
1992,
Pubmed
Zhou-Li,
Antiestrogens prevent the stimulatory effects of L-triiodothyronine on cell proliferation.
1992,
Pubmed
de Launoit,
Influence of L-thyroxine, L-triiodothyronine, thyroid stimulating hormone, or estradiol on the cell kinetics of cultured mammary cancer cells.
1989,
Pubmed